Last reviewed · How we verify
COVID-19 prevention in individuals 5 years of age and older
Approved treatments
- bivalent BNT162b2 (original/Omi BA.4/BA.5) · Pfizer
- BNT162b6 Bivalent (Original/OMI BA.4/BA.5) · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- COVID-19 prevention in individuals 5 years of age and older patent landscape — cliff calendar, originator estates, attackable patents
- COVID-19 prevention in individuals 5 years of age and older treatment landscape brief
- COVID-19 prevention in individuals 5 years of age and older treatment updates RSS
Frequently asked questions about COVID-19 prevention in individuals 5 years of age and older
What drugs treat COVID-19 prevention in individuals 5 years of age and older?
Tracked treatments include bivalent BNT162b2 (original/Omi BA.4/BA.5), BNT162b6 Bivalent (Original/OMI BA.4/BA.5).
What is the treatment for COVID-19 prevention in individuals 5 years of age and older?
Standard treatment for COVID-19 prevention in individuals 5 years of age and older includes bivalent BNT162b2 (original/Omi BA.4/BA.5), BNT162b6 Bivalent (Original/OMI BA.4/BA.5). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: COVID-19 prevention in individuals 5 years of age and older patent cliff · COVID-19 prevention in individuals 5 years of age and older CI report
- Treatment: bivalent BNT162b2 (original/Omi BA.4/BA.5) · Pfizer
- Treatment: BNT162b6 Bivalent (Original/OMI BA.4/BA.5) · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing